BPC-157 is a synthetic 15-amino-acid research peptide (CAS 137525-51-3, molecular formula C62H98N16O22) supplied in Australia by PhaseOne at ≥98% HPLC-verified purity, available in 5mg and 10mg vials. It is studied for its interaction with regenerative signalling pathways, cellular communication systems, and tissue-related research applications, and is one of the most widely discussed compounds within Australian peptide research communities.
PhaseOne research peptides are manufactured to research-grade standards and independently third-party tested for purity, identity, and consistency, with every order shipped Australia-wide. Each batch is backed by verified HPLC analysis and a Certificate of Analysis (COA) for full transparency. (!) Full Certificate of Analysis available for every batch view here.
BPC-157 is commonly classified as a regenerative research peptide, frequently discussed within Australian peptide research communities alongside recovery and tissue-related peptide research, cellular signalling pathways, gut-related peptide studies, and peptide receptor activity. (!) Learn more in our regenerative peptide guide view here.
Published BPC-157 research has expanded significantly in recent years, with growing scientific interest in cellular signalling, tissue-related and recovery peptide pathways, gut-related peptide signalling, peptide receptor interactions, and metabolic signalling pathways. BPC-157 remains one of the most widely searched research peptides in Australia, as additional clinical and laboratory findings continue to emerge. (!) Explore more BPC-157 peptide research guides view here.
BPC-157 is supplied as a lyophilised powder for improved stability during storage and shipping across Australia. Unreconstituted vials should be kept refrigerated and protected from direct light, and are commonly reconstituted using bacteriostatic water prior to research preparation. (!) Read our reconstitution guide or bacteriostatic water guide.
As interest in research peptides grows across Australia, transparency and third-party testing have become increasingly important to Australian peptide buyers. All PhaseOne research peptides are supported by third-party HPLC testing, verified COA reporting, research-grade manufacturing standards, and Australia-wide access. (!) View our COA library.
HPLC testing refers to High Performance Liquid Chromatography, an analytical method used to verify peptide purity and compound identity - a standard PhaseOne applies to every research peptide sold in Australia.
Yes - BPC-157 is frequently studied alongside TB-500 for complementary recovery and tissue-related research, and is available as a combined preparation. (!) View our TB-500 or BPC-157 + TB-500 Blend.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.
